These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 4152152
1. [Prevention and treatment of motion sickness]. Marks E, Swiecicki W. Wiad Lek; 1974 Jan 01; 27(1):37-42. PubMed ID: 4152152 [No Abstract] [Full Text] [Related]
2. Influence of the drugs on the immuno-allergic reactivity. IV. The action of tranquillizers on passive anaphylaxis in guinea-pig. Cîrstea M, Boroş I, Suhaciu G. Rev Roum Morphol Physiol; 1974 Jan 01; 20(1):35-9. PubMed ID: 4157130 [No Abstract] [Full Text] [Related]
3. [On the prevention of air sickness in pilots]. Borghesan C, Caporale R. Riv Med Aeronaut Spaz; 1966 Dec 01; 29():Suppl:374-97. PubMed ID: 4386916 [No Abstract] [Full Text] [Related]
4. [The modification of experimental ulcer in immobilized rats by different pharmacologic agents]. Schramm H. Dtsch Z Verdau Stoffwechselkr; 1968 Dec 01; 28(5):305-12. PubMed ID: 4389534 [No Abstract] [Full Text] [Related]
8. Promethazine as a motion sickness treatment: impact on human performance and mood states. Cowings PS, Toscano WB, DeRoshia C, Miller NE. Aviat Space Environ Med; 2000 Oct 01; 71(10):1013-22. PubMed ID: 11051308 [Abstract] [Full Text] [Related]
9. Patient Notes: motion sickness. Setness PA, Van Beusekom M. Postgrad Med; 2004 Oct 01; 116(4):64. PubMed ID: 15510594 [No Abstract] [Full Text] [Related]
10. Motion-sickness medications for aircrew: impact on psychomotor performance. Paul MA, MacLellan M, Gray G. Aviat Space Environ Med; 2005 Jun 01; 76(6):560-5. PubMed ID: 15945400 [Abstract] [Full Text] [Related]
11. [Experience in the use of tazepam (nozepam) and antihistamine preparations in the treatment of pruritus]. Skorinkina LE, Poliakov VA. Vestn Dermatol Venerol; 1983 Sep 01; (9):55-7. PubMed ID: 6139926 [No Abstract] [Full Text] [Related]
12. [The medical treatment of vertigo in otological practice]. Pignataro O, Caroggio A. Arcisp S Anna Ferrara; 1968 Sep 01; 21():Suppl:861-72. PubMed ID: 4389633 [No Abstract] [Full Text] [Related]
13. [Problems in the drug prevention of the seasickness syndrome (motion sickness)]. Shashkov VS, Sabaev VV, Il'ina SL, Galle RR. Farmakol Toksikol; 1987 Sep 01; 50(3):5-20. PubMed ID: 2886362 [No Abstract] [Full Text] [Related]
14. Psychophysiological aspects of motion sickness. Murray JB. Percept Mot Skills; 1997 Dec 01; 85(3 Pt 2):1163-7. PubMed ID: 9450266 [Abstract] [Full Text] [Related]
15. The prevention of motion sickness in orbital flight. Graybiel A. Life Sci Space Res; 1976 Dec 01; 14():109-18. PubMed ID: 11977268 [Abstract] [Full Text] [Related]
16. [Motion sickness and its treatment (author's transl)]. Petrin A. Schweiz Rundsch Med Prax; 1974 Jan 22; 63(3):79-81. PubMed ID: 4153225 [No Abstract] [Full Text] [Related]
17. Theory of antimotion sickness drug mechanisms. Wood CD, Graybiel A. Aerosp Med; 1972 Mar 22; 43(3):249-52. PubMed ID: 4402925 [No Abstract] [Full Text] [Related]
18. [Therapy of spastic syndromes]. Hartmann-von Monakow K. Bibl Psychiatr Neurol; 1969 Mar 22; 139():114-23. PubMed ID: 4257720 [No Abstract] [Full Text] [Related]
19. To the antineurotic effect of prothidryl and its tolerance. Boucek J. Act Nerv Super (Praha); 1972 Mar 22; 14(2):121-2. PubMed ID: 4402691 [No Abstract] [Full Text] [Related]
20. Effects of some motion sickness suppressants on static and dynamic tracking performance. Schroeder DJ, Collins WE, Elam GW. Aviat Space Environ Med; 1985 Apr 22; 56(4):344-50. PubMed ID: 3994616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]